Login / Signup

Evaluating the Benefits and Risks of Ex Vivo Liver Resection and Autotransplantation in Treating Hepatic End-stage Alveolar Echinococcosis.

Yiwen QiuBin HuangXianwei YangTao WangShu ShenYi YangWentao Wang
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
ELRA was significantly beneficial in selected patients with end-stage AE compared with nonsurgical treatment. The timing of conducting ELRA remarkably affected the short-term risk of mortality and should be carefully determined.
Keyphrases
  • cardiovascular events
  • human health
  • risk assessment
  • type diabetes
  • combination therapy